Clarivate has announced the agenda for its 16th annual Pharmavision India conference, scheduled for September 3, 2025, at the Taj Krishna in Hyderabad. The event will bring together global pharmaceutical leaders, policymakers, regulators, and industry innovators to discuss the shifts shaping India’s life sciences and healthcare sector.
The program will explore market dynamics driven by upcoming drug patent expiries, the expansion of biosimilars, evolving U.S. tariff policies, rising regulatory demands, and the ongoing challenge of improving access to affordable medicines. Participants will also assess how Indian pharmaceutical companies are positioned to respond to these changes, focusing on leveraging cost advantages, supply chain resilience, and regulatory readiness to expand global reach.
Conference sessions will highlight India’s transition from generics production to broader roles in global healthcare. Topics will include strategies for capturing opportunities from the patent cliff and biosimilar expansion, pathways to enter cost-sensitive markets, approaches to regulatory preparedness, and methods to strengthen supply chains. Industry case studies will illustrate how Indian firms contribute to innovation and expand access to essential medicines.
The event underscores India’s growing influence in the global pharmaceutical value chain. Discussions centered on sustainable, innovation-driven approaches to healthcare solutions that support long-term global health priorities.
Click here to read the original press release.
